These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 8309371)

  • 1. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
    Morris NV; Abramson MJ; Strasser RP
    Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of clinical score and lung function tests in the classification of asthma by severity of disease].
    Nakaie CM; Rozov T; Manissadjian A
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(2):68-74. PubMed ID: 9699357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
    Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
    Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
    Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
    Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between clinical classification, PEF and FEV1: guidelines and reality.
    Palma-Carlos AG; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):130-2. PubMed ID: 12793116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of symptom and clinical measures of asthma severity for primary outpatient assessment of adult asthma.
    Ng TP
    Br J Gen Pract; 2000 Jan; 50(450):7-12. PubMed ID: 10695059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of maximum expiratory volume per second and peak expiratory flow monitoring in asthma. 77 patients].
    Chatti S; Tabka Z; Debbabi F; Bousoffara R; Latiri I; Masmoudi K; Slama R; Mrizek N; Zbidi A
    Tunis Med; 2001 Jan; 79(1):32-7. PubMed ID: 11332341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
    Chipps BE; Spahn JD; Sorkness CA; Baitinger L; Sutton LB; Emmett AH; Dorinsky PM
    J Pediatr; 2006 Apr; 148(4):517-21. PubMed ID: 16647416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical measures associated with FEV1 in persons with asthma requiring hospital admission.
    Arnold DH; Gebretsadik T; Minton PA; Higgins S; Hartert TV
    Am J Emerg Med; 2007 May; 25(4):425-9. PubMed ID: 17499661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of bronchial asthma according to steroid and immunosuppressive treatment].
    Nagasaka Y; Nakajima S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():134-9. PubMed ID: 8752496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clinical classification, PEF and FEV1: guidelines and reality.
    Palma-Carlos AG; Palma-Carlos ML
    Allerg Immunol (Paris); 2002 Oct; 34(8):274-6. PubMed ID: 12449664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of questioning asthma to assess asthma control in general practice.
    Hagmolen Of Ten Have W; van den Berg NJ; van der Palen J; van Aalderen WM; Bindels PJ
    Respir Med; 2008 Aug; 102(8):1153-8. PubMed ID: 18573649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma control test and peak expiratory flow rate: independent pediatric asthma management tools.
    Chan M; Sitaraman S; Dosanjh A
    J Asthma; 2009 Dec; 46(10):1042-4. PubMed ID: 19995144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Symptoms, FEV1/FVC, and peak flow as indices of the control of asthma].
    Zang M; Nishimura K; Ikeda A; Tsukino M; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):270-4. PubMed ID: 8778465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on peak expiratory flow monitoring maneuver as compared to forced expiratory flow maneuver].
    Nagasaka Y; Fujita E; Hazu R; Nishimura N; Nakajima S
    Arerugi; 1996 Jan; 45(1):34-40. PubMed ID: 8851314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portable spirometry during acute exacerbations of asthma in children.
    Langhan ML; Spiro DM
    J Asthma; 2009 Mar; 46(2):122-5. PubMed ID: 19253115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peak expiratory flow rate control chart in asthma care: chart construction and use in asthma care.
    Boggs PB; Wheeler D; Washburne WF; Hayati F
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):552-62. PubMed ID: 9892027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.